Activation of Innate Immunity in Graft-versus-Host Disease: Implications for Novel Targets?

被引:9
|
作者
Zeiser, Robert [1 ]
机构
[1] Univ Freiburg, Med Ctr, Dept Hematol & Oncol, D-79106 Freiburg, Germany
关键词
Graft-versus-host disease; Danger-associated molecular patterns; Innate immunity; Adenosine triphosphate; Uric acid; Purinergic receptors; Pattern recognition receptors; Syk; JAK1/2; RelB; STEM-CELL TRANSPLANTATION; T-CELLS; TYROSINE KINASE; DENDRITIC CELLS; INHIBITION; INFLAMMATION; BLOCKADE; GVHD; SYK; ATP;
D O I
10.1159/000381296
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Acute graft-versus-host disease (GvHD) is mediated by alloreactive donor-derived T cells with a suitable T cell receptor recognizing recipient major histocompatibility complex or minor histocompatibility antigens. However, the process of T cell activation and tissue injury sensing is also dependent on innate immune cells and non-hematopoietic cells. Different cell types of the innate immune system have the ability to sense danger-associated and pathogen-associated molecular patterns via pattern recognition receptors which can be transmembrane Toll-like receptors or cytoplasmic nucleotide-binding oligomerization domain-like receptors. Infectious stimuli include bacterial, viral, and fungal components, while non-infectious stimuli can be components derived from damaged cells or extracellular matrix. A better understanding of the complex sensing and effector mechanisms of innate immune cells in GvHD may help to improve preventive and therapeutic strategies in GvHD.
引用
收藏
页码:239 / 243
页数:7
相关论文
共 50 条
  • [1] Danger signals activating innate immunity in graft-versus-host disease
    Robert Zeiser
    Olaf Penack
    Ernst Holler
    Marco Idzko
    [J]. Journal of Molecular Medicine, 2011, 89
  • [2] Danger signals activating innate immunity in graft-versus-host disease
    Zeiser, Robert
    Penack, Olaf
    Holler, Ernst
    Idzko, Marco
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2011, 89 (09): : 833 - 845
  • [3] Novel targets in the treatment of chronic graft-versus-host disease
    A Im
    F T Hakim
    S Z Pavletic
    [J]. Leukemia, 2017, 31 : 543 - 554
  • [4] Novel targets in the treatment of chronic graft-versus-host disease
    Im, A.
    Hakim, F. T.
    Pavletic, S. Z.
    [J]. LEUKEMIA, 2017, 31 (03) : 543 - 554
  • [5] NATURAL IMMUNITY AND GRAFT-VERSUS-HOST DISEASE
    GRATAMA, JW
    LIPOVICHOOSTERVEER, MA
    RONTELTAP, C
    SINNIGE, LGF
    JANSEN, J
    VANDERGRIEND, RJ
    BOLHUIS, RLH
    [J]. TRANSPLANTATION, 1985, 40 (03) : 256 - 260
  • [6] Pathogenesis of graft-versus-host disease: innate immunity amplifying acute alloimmune responses
    Yoshinobu Maeda
    [J]. International Journal of Hematology, 2013, 98 : 293 - 299
  • [7] Pathogenesis of graft-versus-host disease: innate immunity amplifying acute alloimmune responses
    Maeda, Yoshinobu
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (03) : 293 - 299
  • [8] Innate protection from graft-versus-host disease
    Cupedo, Tom
    [J]. BLOOD, 2014, 124 (05) : 673 - 675
  • [9] Innate Lymphoid Cells in Graft-Versus-Host Disease
    Konya, V.
    Mjosberg, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 (11) : 2795 - 2801
  • [10] HERPESVIRUS IMMUNITY AND ACUTE GRAFT-VERSUS-HOST DISEASE
    GRATAMA, JW
    STIJNEN, T
    WEILAND, HT
    HEKKER, AC
    DEGAST, GC
    ZWAAN, FE
    WEIJERS, TF
    DAMARO, J
    THE, TH
    VOSSEN, JMJJ
    [J]. LANCET, 1987, 1 (8531): : 471 - 474